SYO-1, a synovial sarcoma cell line carrying SS18 (SYT)-SSX2 fusion gene, underwent apoptosis upon treatment with ZSTK474, as determined by emergence of cleaved PARP (Figure 7A). The gene discussed is SSX2; the disease is synovial sarcoma.